Russell Investments Group
ROIV icon

Russell Investments Group’s Roivant Sciences ROIV Stock Holding History

Russell Investments Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Sell
526,725
-180,446
-26% -$5.33M 0.02% 769
2026
Q1 		$19.6M Buy
707,171
+617,341
+687% +$15.9M 0.02% 654
2025
Q4 		$1.95M Buy
89,830
+45,022
+100% +$888K ﹤0.01% 1877
2025
Q3 		$678K Buy
44,808
+33,341
+291% +$413K ﹤0.01% 2351
2025
Q2 		$129K Buy
11,467
+6,879
+150% +$74.6K ﹤0.01% 2760
2025
Q1 		$46.3K Buy
4,588
+2,233
+95% +$24.1K ﹤0.01% 2929
2024
Q4 		$27.9K Buy
2,355
+1,948
+479% +$23K ﹤0.01% 2949
2024
Q3 		$4.7K Sell
407
-255
-39% -$2.9K ﹤0.01% 3229
2024
Q2 		$7K Buy
662
+614
+1,279% +$6.73K ﹤0.01% 3150
2024
Q1 		$506 Sell
48
-1,536
-97% -$16.6K ﹤0.01% 3208
2023
Q4 		$17.8K Buy
+1,584
New +$15.4K ﹤0.01% 2757

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Russell Investments Group's ROIV Position: Q2 2026 in Review

Russell Investments Group reduced its Roivant Sciences (ROIV) stake by 26% in Q2 2026, selling an estimated $5.33M and leaving 526,725 shares worth $18.6M. The position accounts for 0.02% of the portfolio, ranked #769.

Russell Investments Group first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.6M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Russell Investments Group held 526,725 shares of Roivant Sciences worth $18.6M as of Q2 2026.
  • Russell Investments Group sold 180,446 Roivant Sciences shares in Q2 2026, an estimated $5.33M.
  • Roivant Sciences made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #769 holding.
  • Russell Investments Group first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • Russell Investments Group's Roivant Sciences position peaked at $19.6M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.